1-3 of 3
Tatiana Zavorotinskaya
Close
Sort by
Journal Articles

CD73 Inhibition Overcomes Immunosuppression and Triggers Autologous T-Cell Mediated Multiple Myeloma Cell Lysis in the Bone Marrow Milieu

Arghya Ray, Melissa R Junttila, Ting DU, Dena Sutimantanapi, Xi Chen, Bob Warne, Jae Chang, Brian Blank, Kejia Wu, Jared Moore, Chudi Ndubaku, Tatiana Zavorotinskaya, Omar Nadeem, Lori Friedman, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood
Blood (2021) 138 (Supplement 1): 2675.
https://doi.org/10.1182/blood-2021-148174
Published: 2021
Journal Articles

The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models

Pablo D Garcia, PhD, John L Langowski, Ph.D., Jocelyn Holash, Ph.D., Matthew Burger, Ph.D., Richard Zang, Ph.D., Tatiana Zavorotinskaya, PhD, Christie Fanton, PhD, Abdel Saci, Ph.D., Joseph Growney, Ph.D., K. Gary Vanasse, M.D.
Journal: Blood
Blood (2013) 122 (21): 1666.
https://doi.org/10.1182/blood.V122.21.1666.1666
Published: 2013
Journal Articles

Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation

Jing Lu, Tatiana Zavorotinskaya, Yumin Dai, Xiao-Hong Niu, Joseph Castillo, Janet Sim, Jianjun Yu, Yingyun Wang, John L. Langowski, Jocelyn Holash, Kevin Shannon, Pablo D. Garcia
Journal: Blood
Blood (2013) 122 (9): 1610–1620.
https://doi.org/10.1182/blood-2013-01-481457
Published: 2013
Includes: Supplemental data